
    
      The most commonly used antibiotics in infants with complicated intra-abdominal infections are
      not labeled for use in this population because safety and efficacy data are lacking. This
      study will provide the safety information required for labeling. In addition, the
      pharmacokinetics(PK) and effectiveness data will also be collected during this study.
    
  